Association between Hyperuricemia and Ischemic Stroke: A Case-Control Study

Objective: To And the association between hyperuricemia and ischemic stroke. Study Design: Case-control study. Place and Duration of Study: Departments of Medicine and Neurology, Mayo Hospital, Lahore, from October 2015 to September 2016. Methodology: A total of 100 patients were recruited in the st...

Full description

Saved in:
Bibliographic Details
Published inJournal of the College of Physicians and Surgeons--Pakistan Vol. 30; no. 8; pp. 853 - 856
Main Authors Fatima, Tooba, Iftikhar, Sadaf, Qureshi, Irshad Hussain
Format Journal Article
LanguageEnglish
Published College of Physicians and Surgeons Pakistan 01.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective: To And the association between hyperuricemia and ischemic stroke. Study Design: Case-control study. Place and Duration of Study: Departments of Medicine and Neurology, Mayo Hospital, Lahore, from October 2015 to September 2016. Methodology: A total of 100 patients were recruited in the study. Fifty cases were of acute ischemic stroke and fifty were age- and gender-matched healthy controls. Serum uric acid level was estimated by photometry method at the time of admission. Hyperuricemia was defined as the serum uric acid level of more than 6 mg/dl. Results: Mean serum uric acid levels in cases and controls were 5.996 [+ or -] 1.99 mg/dl and 5.042 [+ or -] 0.91 mg/dl, respectively. Hyperuricemia was present in 23 (46%) patients with ischemic stroke and in 10 (20%) controls. Among ischemic stroke patients, the frequency of hyperuricemia was significantly higher than in controls (p-value =0.006, Odds Ratio (OR) =3.41.) Conclusion: Serum uric acid was found significantly elevated in ischemic stroke patients versus controls with 3.41 times more risk of having hyperuricemia in ischemic stroke patients. Key Words: Hyperuricemia, Ischemic stroke, Serum uric acid (SUA).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1022-386X
1681-7168
DOI:10.29271/jcpsp.2020.08.853